There is increasing demand from payers to gather evidence on the safety of medications used in the general population post-commercialization. Conducting a literature review involving critical appraisal is essential to better understand the research topic and assess the validity of the research findings. UBC can conduct literature reviews and other real-world evidence generation studies for your product.
Recruiting patients and sites on-time and on-budget is one of our clients' top concerns when it comes to clinical development. To help solve for this, we combined all of the data within the Express Scripts family — more than 130 million patient lives — into a single, de-identified, HIPAA- and Safe-Harbor-compliant platform called MediCUBE®.
Unlike controlled studies, observational studies have the potential to collect data on thousands – even millions – of patients. Increasingly, manufacturers are asked for information and data that only these kinds of studies can provide.
Observational studies can be used to help manufacturers and their stakeholders understand the clinical, patient-centered, and economic burden of disease, as well as the value of different treatments in reducing that burden.
Last week, more than 100 senior Late Phase pharmaceutical professionals and key opinion leaders representing Medical and Scientific Affairs, Health Economics and Outcomes Research, Safety and Risk Management, Regulatory, Market Access and Drug Reimbursement met in Berlin, Germany, at the Third Annual Medical Affairs Leaders Forum.
The annual Managed Markets Summit is a great opportunity to learn the pharma industry’s ever-changing landscape from its leaders. This year is even more critical in light of the implementation of the Affordable Care Act. The new law is rapidly changing many aspects of healthcare, from reimbursement strategies to emphasizing data-driven care.
Experts from UBC and Express Scripts are joining more than 60 other faculty members at this year’s conference to discuss the impacts of the ACA along with other key trends in the marketplace.
Traditionally, chart review studies have been employed to evaluate burden of illness and patterns of care, but, increasingly, this methodology is being applied to meet marketing authorization and risk management data requirements including data that reflect patterns of off label medication use.